QNRX
NASDAQ
$4.26
Quoin Pharmaceuticals Ltd (QNRX)
Quoin Pharmaceuticals Ltd (QNRX) is an innovative biotechnology firm dedicated to developing cutting-edge therapeutics for rare diseases, addressing significant unmet medical needs in the healthcare landscape. Leveraging advanced drug delivery technologies, Quoin enhances the efficacy and safety of its treatment pipeline, thereby positioning itself for impactful clinical advancements. The company emphasizes strategic collaborations and groundbreaking research initiatives, aiming to create substantial value for both patients and investors while establishing a formidable presence in the specialty pharmaceuticals sector.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $21.40 (+402.35%)
Market Cap
$12M
P/B Ratio
0.99
Free Cash Flow Yield
-90.13%
Price Chart
Valuation
Market Cap$12M
P/B0.99
Profitability
EBITDA-$17M
EPS-$10.55
Financial Health
Free Cash Flow Yield-90.13%
Growth & Risk
Sharpe Ratio0.31